Abstract
Idiopathic portal hypertension (IPH) is characterized by noncirrhotic portal hypertension due mainly to increased intrahepatic, presinusoidal resistance to portal blood flow. Marked splenomegaly is always seen in IPH. To clarify the pathogenetic significance of splenomegaly, immunohistochemical expression of inducible nitric oxide synthese (iNOS), endothelial NOS (eNOS), and endothelin-1 (ET-1) in spleens from patients with IPH was examined. Sinus lining cells of IPH spleens showed diffuse and strong expression of iNOS and eNOS. Sinus lining cells of spleens from patients with liver cirrhosis (LC) also showed positive signals for iNOS and eNOS, but the staining intensity was significantly weak. ET-1 was detectable in only a few mononuclear leukocytes in the red pulp of both IPH and LC spleens. These results suggest that NO liberated in spleen, rather than ET-1, is responsible for the dilatation of splenic sinuses, leading to splenomegaly, and thereby contributes to portal hypertension in IPH.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K (2001) Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 197:65–76
Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, Kurumaya H, Harada A, Obata H (1996) Histopathology of the liver in noncirrhotic portal hypertension of unknown aetiology. Histopathology 28:195–204
Okudaira M, Ohbu M, Okuda K (2002) Idiopathic portal hypertension and its pathology. Semin Liver Dis 22:59–72
Okuda K, Kono K, Ohnishi K, et al. (1984) Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86:600–610
Tsuneyama K, Ohba K, Zen Y, Sato Y, Niwa H, Minato H, Nakanuma Y (2003) A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 43:55–61
Tsuneyama K, Kouda W, Nakanuma Y (2002) Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study. Pathol Res Pract 198:597–603
Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, Puri P, Mitra SK, Suri S (2002) Noncirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 17:6–16
Maesawa C, Sakuma T, Sato T, Masuda T, Muro-oka G, Satodate R (1995) Structural characteristic of splenic sinuses in idiopathic portal hypertension. Pathol Int 45:642–648
Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M, Sugimachi K (2002) Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol 17:59–65
Kaido T, Oe H, Yoshikawa A, Okajima A, Imamura M (2004) Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepatogastroenterology 51:547–551
Rockey D (1997) The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 25:2–5
Wiest R, Groszmann RJ (1999) Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 19:411–426
Farzaneh-Far R, Moore K (2001) Nitric oxide and the liver. Liver 21:161–174
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863–2867
Nagasue N, Dhar DK, Yamanoi A, Emi Y, Udagawa J, Yamamoto A, Tachibana M, Kubota H, Kohno H, Harada T (2000) Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis. Hepatology 31:1107–1114
Ohara N, Futagawa S, Watanabe S, Fukasawa M, Takamori S (2001) Clinical investigation of endothelin-1 and nitric oxide in patients with portal hypertension focusing on plasma levels and immunohistological staining of liver tissues. Hepatol Res 21:40–54
Yamamoto K (1978) Morphological studies of the spleen in splenomegalic liver cirrhosis comparing with the spleen in idiopathic portal hypertension (so-called Banti’s syndrome without liver cirrhosis). Acta Pathol Jpn 28:891–905
Cavalli G, Re G, Casali AM, Monari P (1982) The microvascular architecture of spleen in congestive splenomegaly. A morphological-histometric study. Pathol Res Pract 174:131–146
Suzuki T (1972) Application of scanning electron microscopy in the study of the human spleen: three dimensional fine structure of the normal red pulp and its changes as seen in splenomegalias associated with Banti’s syndrome and cirrhosis of the liver. Nippon Ketsueki Gakkai Zasshi 35:506–522
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
Kamath PS, Carpenter HA, Lloyd RV, McKusick MA, Steers JL, Nagorney DM, Miller VM (2000) Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver. Liver Transpl 6:596–602
Blendis L, Wong F (2001) The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 89:221–231
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sato, Y., Sawada, S., Kozaka, K. et al. Significance of Enhanced Expression of Nitric Oxide Syntheses in Splenic Sinus Lining Cells in Altered Portal Hemodynamics of Idiopathic Portal Hypertension. Dig Dis Sci 52, 1987–1994 (2007). https://doi.org/10.1007/s10620-006-9146-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9146-9